Skip to main content

Animations

MJFF Publications

5561 - 5570 of 8818 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2024
  • 2024
  • 2025
  • 2025
  • Summary Details
    RESTRICTED
    Title: Placebo Effects in the Treatment of Depression—Implications for the Psychedelic Renaissance
    Journal Name: Neurologic Clinics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ncl.2025.08.009
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Hope vs. Hype I: It is time to redefine and rename Parkinson disease based on alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107983
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108059
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Subthalamic deep brain stimulation alleviates the gait sequence effect and freezing of gait in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108062
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Hemispheric lateralization of dopamine transporter binding in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108076
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping review
    Journal Name: Pharmacological Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pharmr.2025.100094
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100236
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Conquering Neurologic Diseases in Primary Care
    Journal Name: Primary Care: Clinics in Office Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET study
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100353
    Citation Count: 1
  • Summary Details
    OPEN
    Title: PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysis
    Journal Name: Software Impacts
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.simpa.2025.100766
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.